Below are the most recent publications written about "Antibodies, Monoclonal, Humanized" by people in Profiles.
-
Bhatt SP, Martinez FJ, Satia I, Anzueto A, Bourbeau J, Papi A, Korn S, Deslée G, Xia C, Heble J, Soliman M, Bafadhel M. Dupilumab in chronic obstructive pulmonary disease: a pooled analysis of emergency department visits, hospital admissions, and systemic corticosteroid use. Am J Respir Crit Care Med. 2026 Sep 01; 212(9):2011-2021.
-
Criner GJ, Watz H, Han MK, Martinez FJ, Gould S, Min J, Biswas A, Kolterer S, Singh D. Mepolizumab efficacy in chronic obstructive pulmonary disease: insights from longitudinal patterns of blood eosinophil counts and their variability across 3 clinical trials. Am J Respir Crit Care Med. 2026 Sep 01; 212(9):2022-2035.
-
Mina R, Terpos E, Cani L, Nooka A, Trudel S, Voorhees P, Mian H, Dhakal B, Usmani S, Richter J, Popat R, Mateos MV, Lonial S. Belantamab Mafodotin for Patients With Multiple Myeloma: Clinical Development and Practical Strategies for Dose Optimization and Toxicity Management. Clin Lymphoma Myeloma Leuk. 2026 Sep; 26(9):609-622.
-
Lanni J, Bose A, Cachia D. Outcomes in checkpoint inhibitor induced neuromuscular immune related adverse events: A case series. J Neuroimmunol. 2026 Sep; 418:578986.
-
Wu HL, Webb GM, Fuchs SP, Pessoa CT, Hwang JM, Fisher HK, McCullen AJ, Humkey MC, Brown MK, Waytashek CM, Boyle CD, Kukula KA, Potter SK, Devlin G, Elmore ZC, Hull JA, Zikos J, Swanson T, Armantrout K, Chun K, Crank H, Bailey L, White R, Barber-Axthelm A, Fischer M, Smedley JV, Axthelm MK, Fennessey CM, Keele BF, Desrosiers RC, Magnani DM, Asokan A, Sacha JB. Adeno-associated virus gene therapy-mediated CCR5 blockade suppresses virus replication long term in SHIV-infected macaques. Sci Transl Med. 2026 Apr 29; 18(847):eadw1976.
-
Hamadeh IS, Merz M, Derkach A, Modelevsky L, Lesokhin AM, Mailankody S, Hultcrantz ML, Tan CR, Hassoun H, Shah UA, Maclachlan K, Rajeeve S, Hashmi H, Maura F, Firestone RS, Wang AX, Amin A, Patel D, Scordo M, Shah GL, Landau HJ, Giralt S, Usmani SZ, Korde N. Low Dose Tocilizumab for Mitigation of Cytokine Release Syndrome With T-Cell Engaging Bispecific Antibodies. Clin Lymphoma Myeloma Leuk. 2026 Jun; 26(6):e802-e810.
-
Porter RL, Zhou Y, Eskndir N, Hayes M, Polak M, Lee EK, Krasner C, Campos S, Wright AA, Liu JF, Stover EH, Sawyer H, Xiong N, Pfaff KL, Rodig SJ, Tayob N, Zweizig S, John V, Veneris J, Matulonis UA, Konstantinopoulos PA. Mirvetuximab soravtansine plus pembrolizumab in recurrent folate receptor alpha-positive uterine serous carcinoma: a phase II trial. Nat Commun. 2026 Mar 26; 17(1).
-
Gabryszewski SJ, Hirabayashi K, Botdorf M, Maltenfort M, Forrest CB, Guilbert TW, Schutt M, Morizono H, Vazquez Garcia G, Garza-Mayers AC, Hernandez JD, Anvari S, Rao S, Spergel JM. Incidence of autoimmune diseases in children with atopy treated with dupilumab. J Allergy Clin Immunol. 2026 08; 158(2):533-541.
-
Marzo-Ortega H, Navarro-Compan V, Dubreuil M, Mease PJ, Magrey M, Rudwaleit M, D'Agostino MA, Gaffney K, Kay J, de la Loge C, Massow U, Taieb V, Vaux T, Deodhar A. Sustained improvements in spinal pain, morning stiffness, fatigue, sleep, physical function and overall health-related quality of life with bimekizumab in patients with axial spondyloarthritis: 2-year results from two phase 3 studies. RMD Open. 2025 11 28; 11(4).
-
Hamadeh IS, Modelevsky L, Chan A, Mitchell A, Firestone RS, Wang AX, Shekarkhand T, Korde N, Hultcrantz ML, Lesokhin AM, Mailankody S, Hassoun H, Shah UA, Maclachlan K, Rajeeve S, Hashmi H, Patel D, Shah GL, Scordo M, Landau HJ, Giralt S, Usmani SZ, Tan CR. Defining the Rates of Cytokine Release Syndrome Associated With Talquetamab Step-up Doses. JCO Oncol Pract. 2026 Jun; 22(6):1105-1111.